MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF
Cannabis Law Report
FEBRUARY 23, 2022
This is a high value, high margin opportunity, and with the only purpose-built facility in North America to receive a domestic GMP licence specifically for the extraction of natural cannabinoids, MediPharm is positioned to capture share in this growing market.
Let's personalize your content